About: Nyrada Inc., a clinical-stage biotechnology company, focuses on the discovery and development of small-molecule therapies for neuroprotection and cardioprotection indications in Australasia. Its lead candidate is Xolatryp, a small-molecule inhibitor targeting the transient receptor potential canonical ion channel subtypes 3, 6, and 7, which is in a Phase IIa clinical trial to treat myocardial ischemia, arrhythmia, stroke, and traumatic brain injury, as well as in a preclinical research stage for oncology indications. Nyrada Inc. was incorporated in 2017 and is based in Sydney, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.46 (-6.12%)
NYR ASX Nyrada Inc
Nyrada Inc share price
NYR price activity
Last Price
$0.460
Change (24hr)
-0.03 AUD (6.12%)
Volume
117.44K
Volume (4w avg)
-
Open
$0.49
Day Range
$0.46 - $0.49
Previous Close
$0.49
Last Trade
30 Oct, 5:10 am GMT+0
Delayed
30 Oct, 5:10 am GMT+0
NYR price performance
Delayed
30 Oct, 5:10 am GMT+0
NYR Market Signals